88. Dhand, R., Dolovich, M., Chipps, B., Myers, T., Restrepo, R., and Farrar.,
J. The role of nebulized therapy in the management of COPD: Evidence
and recommendations. COPD: Journal of Chronic Obstructive Pulmonary
Disease. 2011 (In Press).
87. Zeiger, R., Yegin, F., Simons, T., Haselkorn, T., Rasouliyan, S., Szefler,
S., and Chipps, B. Evaluation of the NHLBI guidelines impairment domain
for the classifying asthma control and predicting asthma exacerbations.
Ann Allergy Asthma Immunol. 2011;108(2):81-87.e3.
82. Chipps, B., Yegin, A., Borish, L., Wenzel, S., Weiss, S., Hayden, M.,
Miller, D., Bleecker, E., Simons, F., Szefler, S., Haselkorn, T. Lessons
learned from the epidemiology and natural history of asthma: Outcomes
and treatment regimens (TENOR) study. J Allergy Clin Immunol. 2011 (In
Press).
86. Sicherer, S., Wood, R., and the SECTION ON ALLERGY AND
IMMUNOLOGY. Allergy Testing in Childhood: Using Allergen-Specific IgE
Tests. Pediatrics. 2012;129(1):193-197.
85. Dhand, R., Dolovich, M., Chipps, B., Myers, T.R., Restrepo, R., Ferrar,
J.R. The role of nebulized therapy in the management of COPD: Evidence
and recommendations. Journal of Chronic Obstructive Pulmonary
Disease. 2012;9:58-72.
84. Zeiger, R., Yegin, A., Simons, E.R., Haselkorn, T., Rasouliyan, L.,
Szefler, S., Chipps, B.E., and the TENOR study group. Evaluation of the
National Heart, Lung, and Blood Institute guidelines impairment domain
for classifying asthma control and predicting asthma exacerbations. Ann
Allergy Asthma Immunol. 2012;108:81-87.
83. Zeiger, R.S., Mellon, M., Chipps, B.E., Murphy, K.R. Schatz, M., Kosinski,
M., Lampl, K., and Ramachandran, S. Test for Respiratory and Asthma
Control in Kids (TRACK™): Clinically Meaningful Changes in Score. J
Allergy Clin Immunol 2011 ( In Press).
82. Chipps, B.E. Letter to the Editor Spirometry Versus Flow Volume
Inspiratory and Expiratory Loop. Annals of Allergy, Asthma, &
Immunology 2011; 107(2): 183.
80. Chipps, B.E. Letter to the Editor Novel Epinephrine Auto-Injector ( NEA):
Sharps Injury Prevention Validation and Comparable Analysis with
Epipen and Twinject. Annals of Allergy, Asthma, & Immunology 2011;
107(3): 286
79. Haselkorn, T., Szefler, S.J., Zeiger, R.S., Chipps, B.E., Fish, J., Kamath, T., Mink, D., and Yegin, A. Economic Burden of Impairment in Children with Severe or Difficult-to-Treat Asthma. Annals of Allergy, Asthma & Immunology 2011
78. Arellano, F.M., Arana, A., Wentwort, C.E., Vidaurre, C.F., and Chipps,B.E.
Prescription Patterns for Asthma Medications in Children and Adolescents in the United States. Pediatric Allergy & Immunology 2011
77. Chipps, B.E., Spector, S., Farrar, J., Carr, W., Meltzer, E., Storms, W., Kaliner, M., Luskin, A., Bukstein, D., Oppenheimer, J., Smart, B., Derebery, J., Harder, J., Dykewicz, M., and Benniger, M. Letter to the Editor Differences in Recommendations Between the Allergic Rhinitis and Its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters. J Allergy Clin Immunol (127)6, 1640-1641.e1.
76. Chipps, B.E., Bacharier, L., and Harder, J. Phenotypic Expressions of Childhood Wheezing and Asthma: Implications for Therapy. Journal of Pediatrics 2011; (158)6: 878-884.
75. Chipps, B.E., Zeiger, R., Murphy, K., Mellon, M., Schatz, M., Kosinski, M., Lampl, K., and Ramachandran, S. Longitudinal Validation of Test for Respiratory and Asthma Control in Kids (TRACK™) in Pediatric Practices. Pediatrics 2011; 127: e737-e747.
74. Sicherer, S.H., Mahr, T.A, and The Section on Allergy and Immunology. Clinical Report- Management of Food Allergy in the School Setting. Pediatrics 2010; 1232-39.
73. Haselkorn, T., Szefler, S.J., Simons, F.E., Mink, D.R., Chipps, B.E., Borish, L., and Wong, D.A. Allergy, Serum immunoglobulin E, and Airflow in Children and Adolescents in Pediatric Allergy Immunol 2010;21: 1157– 1165.
71. Nemr S. Eid, MD, Michael J. Noonan, MD, Bradley Chipps, MD, Bhash Parasuraman, PhD, Christopher J. Miller, Christopher D. O’Brien, MD, PhD. Once vs Twice-Daily Budesonide/Formoterol in 6-15 Year Olds With Stable Asthma: A Randomized Controlled Trial. Pediatrics 2010; 126(3): e565-e575.
69. LaForce, C.F., Carr, W., Tilles, S.A., Chipps, B.E., Storms, W., Meltzer, E.O., and Edwards, M. Evaluation of Olopatatadine Hydrochloride Nasal Spray, 0.6%, used in Combination with an Intranasal Corticosteroid in Seasonal Allergic Rhinitis. Allergy Asthma Proc. 2010; 31:132-140.
67. Benninger, M., Farrar J.R., Blaiss, M., Chipps, B.E., Ferguson, B., Krouse, J.,
Marple, B., Storms, W., and Kaliner, M. Evaluating Approved Medications to Treat Allergic Rhinitis in the United States: An Evidenced-Based Review of Efficacy for Nasal Symptoms by Class. Ann Allergy Asthma Immunol 2010; 104: 13-29.
66. Zeiger, R.S., Chipps, B.E., Haselkorn, T., Rasouliyan, L., Simons, F.E.R.,
and Fish, J.E. Comparison of Asthma Exacerbations in Pediatric and Adult Patients with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol 2009; 24:1106-1108.
65. Haselkorn, T., Fish, J.E., Zeiger, R.S., Szefler, S.J., Miller, D.P., Chipps, B.E., Simons, E.R., Weiss, S.T., Wenzel, S.E., Borish, L., and Bleecker, E.R. Consistently Very Poorly Controlled Asthma by the Impairment Domain of the EPR-3 Guidelines Increases Risk for Future Severe Asthma Exacerbations in the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens Study. J Allergy Clin Immunol 2009; 124: 895-902 e.4.
63. Chipps B.E. and Harder J. Antihistamine treatment for allergic rhinitis: Different routes, different outcomes. Allergy Asthma Proc. 2009 November-December;30(6): 589-594.
62. Kalner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, Lanier BQ, Chipps B. Comparison of olopatadine 0.6% nasal spray versus fluticasone proprionate 50ug in the treatment of seasonal allergic rhinitis patients. Allergy Asthma Proc. 2009 May-June;30(3):255-262.
61. Chipps B.E. Inhaled corticosteroid therapy for patients with persistent
Asthma: Learnings from studies inhaled budesonide. Allergy Athma Proc. 2009; May-June(3): 217-228.
60. Murphy, K.R., Zeiger, R.S., Kosinski, M., Chipps, B.E., Mellon, M., Schatz,
M., Lampl, K., Hanlon, J.T., and Ramachandran, S. Test for Respiratory
and Asthma Control in Kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. J Allergy Clin Immunol 2009; 123:833-39.
59. Miller, DP., Tom, Gladys, Rasouliyan, Lawrence and Chipps, B. Patient-Reported Outcomes among Omalizumab and Salmeterol/Fluticasone Combination Therapy Patients. Journal of Asthma, 46:2,179 — 185
58. Haselkorn, T., Fish, J.E., Chipps, B.E., Miller, D.P., Chen, H., and Weiss, S.T. Effect of Weight Change on Asthma-Related Health Outcomes in Patients with Severe or Difficult to Treat Asthma. Respiratory Medicine 2009;103: 274-283.
55. Chipps, B.E. Asthma in Infants, Children, and Adolescents. Clinical Cornerstone. The Current and Future State of Asthma Treatment. 2008;8:4: 44-58.
54. Chipps, B.E. Update on the 2007 National Asthma Education and Prevention Program: Guidelines for the Treatment of Asthma in Children. Supplement to Consultant for Pediatricians. 2008;7:1.
51. Chipps, B.E., Sezefler, S.J., Simons, E.R., Haselkorn, T., Mink, D.R., Deniz, Y., Lee, J.H., TENOR Study Group. Demographic and Clinical Characteristics of Children and Adolescents with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol. 2007;119:1156-63.
50. Sullivan, S.D., Rasouiyan, L., Russo, P.A., Kamath, T., Chipps, B.E., for the Tenor Study Group. Extent, Patterns, and Burden of Uncontrolled Disease in Severe or Difficult-to-Treat Asthma. Allergy. 2007;62:126-133.
47. Chipps, B.E., Buhl, R., Beeh, K.M., Fox, H., Thomas, K., Reisner, C. Improvement in Quality of Life with Omalizumab in Patients with Sever Allergic Asthma. Current Medical Research and Opinion. 2006;22:2201-2208.
44. Sander, N., Fusco-Walker, S.J., McElvain, J., Chipps, B.E. Running on Empty: The Need for Dose counters on Pressurized Metered-Dose Inhalers. Ann Allergy Asthma Immunol. 2006;97:34-38.
42. Chipps, B.E., Haselkorn, T., Lee, J.H., Miller,
D.P., Wenzel, S.E., Gender Differences in IgE-Mediated Allergic
Asthma in the Epidemiology and Natural History of Asthma: Outcomes
and Treatment Regimens (TENOR) Study. Journal of Asthma, 2006; 43:179-184.
41. Borish, L. Chipps, B.E., Deniz, Y., Zheng,
B., Dolan, C., Total Serum IgE levels in a large cohort of subjects
with severe or difficult to treat asthma. Ann Allergy Asthma Immunol.
2005;95:247-253
37. Ververeli, K., Chipps, B.E. Oral corticosteroid-sparing
effects of inhaled corticosteroids in the treatment of persistent
acute asthma. Ann Allergy Asthma Immunol. 2004;92:512-522.
36. Dolan, C.M., Fraher, K.E., Bleeker, E.R., Borish,
L., Chipps, B.E., Hayden, M.L., et al. Design and baseline characteristics
of The Epidemiology and Natural History of Asthma: Outcomes and
Treatment Regimens (TENOR) study: a large cohort of patients with
severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol.
2004;92:32-39.
35. Chipps, B.E., Schnepp, C.M., Briscoe M. Budesonide
Inhalation Suspension Reduces the Need for Emergency Intervention
in Pediatric Asthma: A Named-Patient Case Series. J Asthma. 2003;
40:895-900.
34. Oppenheimer, J.J., Chipps, B.E., Corbridge
T.C., Fanta, C.H. Acute asthma: The basics of assessment and treatment.
J Respir Dis. 2001; 23:126-141.
33. Abrahams, N.A., Colby, T.V., Chipps, B.E.,
Juris, A.L., Leslie, K.O. Pulmonary hemangiomas of infancy and childhood:
report of two cases and review of the literature. Pediatr Dev Pathol.
2002 May-June; 5 (3): 283-292.
32. Chipps, B.E., Chipps, D.R.: A Review of the
Role of Inhaled Corticosteroids in the Treatment of Acute Asthma.
Clin Pediatrics. 2001; 40:185-189.
31. Aquino, S.L., Schechter, M.S., Chiles C., Ablin,
D.S., Chipps, B.E., Webb, W.R. High-Resolution Inspiratory and Expiratory
CT in Older Children and Adults with Bronchopulmonary Dysplasia.
Amer J Radiol:173:963-967, 1999.
30. Chipps, B.E., Moynihan, R., Schieble, T., Stene,
R., Feaster, W., et al. Infants Undergoing Pyloromyotomy Are Not
at Risk for Postoperative Apnea. Pediatr Pulmonol. 27:278-281, 1999.
27. Loughlin, G.M., Brouillette R.T., Brooke L.J.,
Carroll J.L., Chipps, B.E., et al. Standards and Indications for
Cardiopulmonary Sleep Studies In Children. American Journal of Respiratory
and Critical Care Medicine. Vol 153, No. 2:866-878, 1996.
26. Smith, D.W., Frankel, L.R., Derish, M.T., Moody,
R.R., Black, L.E., Chipps, B.E., Mathers, L.H.: High frequency jet
ventilation in children with the adult respiratory distress syndrome
complicated by pulmonary barotrauma. Pediatr Pulmonol. 15:279-286,
1993.
25. Chipps, B.E., Sullivan, W.F., Portnoy, J.M.,:
Alpha 2A interferon for treatment of bronchiolitis caused by RSV.
Pediatr Infect Dis J. 12:653-658, 1993.
24. Chipps, B.E., Naumann, P.F., Wong, G.A., Raabe,
O.G.: Clinical Comparison of Gentle-Haler Actuator and Aerochamber
Spacer for Metered Dose Inhaler (MDI) Use by Asthmatics. Respir
Care 37:1414-1422, 1992.
23. Chipps, B.E., Blackney, D.A., Moody, R.R.,
Marino, J.T., Black, L.E., Ridell, R.C., Wong, G.A.: Vortan high
output extended aerosol respiratory therapy for delivery on continuously
nebulized terbutaline for the treatment of acute bronchospasm. Pediatric
Asthma, Allergy and Immunology 4:271-277, 1990.
22. Chipps, B.E., McClurg, D., Freidman, E.M.,
Adams, G.L.: Respiratory papillomas: Presentation before six months.
Pediatric Pulmonology 9:125-130, 1990.
21. Davidson Ward, S.L., Keens, T.G., Chan, L.S.,
Ph.D., Chipps, B.E., et al: Sudden Infant Death Syndrome in infants
evaluated by apnea programs in California. Pediatrics 77:451-458,
1986.
20. MacAdams, M.R., White, R.H., Chipps, B.E.,
et al: Reduction of serum testosterone during chronic glucocorticoid
therapy. Annals of internal medicine 104:648-651, 1986.
19. Chipps, B.E., Mak, H., Menkes, H.A., Mellits,
E., Schuberth, K., Talamo, R., Talamo, J., Dermutt, S., Scherr,
M.M.: Do weather conditions change pulmonary function in asthmatics
at summer camp. Journal of Asthma 21:15-20, 1984.
18. Chipps, B.E., Shinnar, S., Pickard, L., Garfinkel,
D.J., Haller, J.A.: Spontaneous resolution of multilobar atelectasis
secondary to fibrinous mediastinitis. Journal of Pediatrics, 100:935-937,
1982.
17. Mak, H., Chipps, B.E., Menkes, H.A., Schuberth,
H.C., Talamo, R.C., Permutt, S.: Diurnal variation of air and helium
- oxygen flow - volume curves in asthmatic children. British J.
Disease of Chest 76:51-56, 1982.
16. Hyatt, A.C., Chipps, B.E., Kumor, K.M., Mellits,
E.D., Lietman, P.S., Rosentein, B.J.: A double blind controlled
trial of anti-pseudomonas chemotherapy of acute respiratory exacerbations
in children with cystic fibrosis. J. Pediatrics 99 (2):307-311,
1981.
15. Boonyaprapa, S., Alderson, P.O., Garfinkel,
D.J., Chipps, B.E., Wagner, N.E., Jr: Detection of pulmonary aspiration
in infants and children with respiratory disease; concise communication.
Journal of Nuclear Medicine Vol 21, #4, 1980.
14. Robotham, J.L., Menkes, H.A., Chipps, B.E.,
et al: A physiologic assessment of segmental bronchial atresia.
American Review of Respiratory Disease 121:533-540, 1980.
13. Chipps, B.E., Kagey - Bobotka, A.K., Valentine,
M.D., Schuberth, K.C., Lichtenstein, L.M.: Diagnosis and treatment
of anaphylactic reaction to hymenoptera stings. J. Pediatrics Vol.
97, No. 2 1977-1984, 1980.
12. Chipps, B.E., Mak, H., Schuberth, L.S., Talamo,
J.H., Scheer, M.S., Menkes, H.A.: Nocturnal oxygen saturation in
normal adolescents and asthmatics. Pediatrics Vol 62:1157, 1980.
11. Robotham, J.L., Chipps, B.E., Dorst, J., Shermeta,
D.W.: Use of CPAP in hemidiaphragm paralysis. Anesthesiology 52:167-170,
1980.
10. Chipps, B.E., Sobotka, A.K., Sanders, J.P.,
Teets, K.C., Norman, P.S., Lichtenstein, L.M.: The effect of theophylline
and terbutaline on immediate skin tests. J. All Clin. Immunol. Vol
65:61, 1980.
9. Chipps, B.E., Alderson, P.O., Roland, J.M.,
Yang, S., Van Aswegen, A., Martinez, C., Rosenstein, B.J.: Non-invasive
evaluation of ventricular function in cystic fibrosis. Journal of
Pediatrics 95:379, 1979.
7. Chipps, B.E., Saulsbury, F.T., Hsu, S.H., Hughes,
W.T., Winklestein, J.A.: Non-candidal infections in children with
chronic mucocutaneous candidiasis. Johns Hopkins Medical Journal
144:175, 1979.
6. Chipps, B.E., Valentine, M.D., Mellits, E.D.,
Talamo, R.C.: Immediate (IgE mediated) skin testing in the diagnosis
of allergic disease. Ann Allergy 41:211, 1978.
5. Chipps, B.E., Winkelstein, J.A., Talamo, R.C.:
IgA deficiency, recurrent pneumonia and bronchiectasis. Chest 73:519,
1978.
4. Chipps, B.E., Swischuk, L.E.: Radiographic single
bone involvement in congenital syphilis. Pediatric Radiology 5:50,
1976.
3. Travis, L.B., Street, L., Smith E., Chipps,
B.E.: Renal involvement in systemic diseases in childhood, in: The
Kidney in Systemic Disease John Wiley & Sons, Inc., New York, 1976.
2. Jorgensen, J.H., Carvajal, H.F., Chipps, B.E.,
Smith, R.F.: Rapid detection of gram-negative bacteriuria by use
of the limulus endotoxin assay. Applied Microbiology 26:38, 1973.
1. Forman, P.M., Chipps, B.E., Myers, G.A.: Managing
chronic subdural hematomas and effusions in infants: A continuing
dilemma. Texas Medicine 70:62, 1974.
